Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
Submitted by
admin
on October 29, 2011 - 12:50pm
Source:
TheStreet.com
News Tags:
Spectrum Pharmaceuticals
Fusilev
colon cancer
Headline:
A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
Do Not Allow Advertisers to Use My Personal information
